Pap Smear For The Breast

What if you could detect the beginnings of breast cancer years before it showed up on a mammogram? That's exactly what a new kind of test is doing.

In today's Medical Moment, a non-invasive test that has the potential to cut breast cancer rates, just like pap smears have cut rates of cervical cancer.

Daily exercise is a must for Susan Burkett.

"Just kind of get rid of all the stress in my life," says Susan Burkett who took the ForeCYTE Breast Health Test.

A top stressor is breast cancer. Susan's breast density increases her risk and makes it harder for mammograms to spot.

"You can have a mammogram that's negative for nothing is suspicious, and by the time you go back for your next one there could be something there," explains Susan.

Doctor Debra Dube says a new test known as ForeCYTE could help Susan and millions like her.

"It's absolutely huge, and, to me, this is a new frontier," says Dr. Debra Dube, MD, with Internal Medicine Connection.

Much like a pap smear, the test detects pre-cancerous cells up to eight years before cancer arises.

"So we can treat much earlier, at the very beginning of a tumor formation," explains Dr. Dube.

Unlike a mammogram, the test is virtually painless. This is Susan's first time.

Doctor Dube uses a device similar to a breast pump to collect cells that line the milk ducts. The cells are then sent to a lab for analysis, helping women like Susan make an informed decision about her future.

"It's peace of mind, I think it's more than anything peace of mind," says Susan.

Doctor Dube says women over 40 should take the test every year and get an annual mammogram.

Women between 18 and 39 can also take the ForCYTE test. The screening is covered by Medicare and private insurance.


TOPIC: Pap Smear For The Breast
REPORT: MB# 3667

BACKGROUND: Breast cancer can be invasive or noninvasive. It tends to be sensitive to the hormone estrogen. This means that estrogen causes the breast cancer tumor to grow. (SOURCE:

SYMPTOMS: Signs and symptoms of breast cancer may include:
* A breast lump or thickening that feels different from the surrounding tissue
* Bloody discharge from the nipple
* Change in the size or shape of a breast
* Changes to the skin over the breast, such as dimpling
* Redness or pitting of the skin over your breast, like the skin of an orange

TREATMENT: The ForeCYTE Breast Health Test is a non-invasive biopsy for the early detection of pre-cancerous cells in the breast. The MASCT system, a modified breast pump, is used to collect nipple aspirate fluid from both breasts. The ForeCYTE Breast Health Test provides cellular-based risk assessment information about your personal breast health. Nipple aspirate fluid cytology in women ages 18-73 has been clinically proven to identify women who are at risk of getting breast cancer in the future, giving you and your healthcare provider valuable information and time to intervene in the process of this disease. (SOURCE:


Atossa Genetics:
(800) 351-3902

If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Céline McArthur at

Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
WNDU - Channel 16 54516 State Road 933 South Bend, IN 46637 Front Desk: 574-284-3000 Newsroom: 574-284-3016 Email:
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 222564931 -